Comparison of inflammation, arterial stiffness and traditional cardiovascular risk factors between rheumatoid arthritis and inflammatory bowel disease

Journal of Inflammation (United Kingdom)

Volumn 11, Issue 1, 2014, Pages

  Fan, Fenling ^a,b,d   Galvin, Abby ^a,b   Fang, Lu ^b   White, David Andrew ^b   Moore, Xiao Lei ^b   Sparrow, Miles ^a   Cicuttini, Flavia ^a,c   Dart, Anthony Michael ^a,b,c  

^a ALFRED HOSPITAL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Arterial stiffness; Inflammation; Inflammatory bowel disease; Pulse wave velocity; Rheumatoid arthritis

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; CYTOKINE RECEPTOR ANTAGONIST; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HYDROXYCHLOROQUINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR ANTAGONIST; MACROPHAGE MIGRATION INHIBITION FACTOR; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; AGE; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE REGRESSION; PULSE WAVE; RHEUMATOID ARTHRITIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84988457225     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/s12950-014-0029-0     Document Type: Article

References (52)

1. Libby P, Ridker PM, Hansson GK: Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009, 54:2129-2138.
2. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J: C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375:132-140.
3. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG: C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh artery study. Circulation 2005, 112:976-983.
4. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387-1397.
5. del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A: High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001, 44:2737-2745.
6. Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV: Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006, 33:2167-2172.
7. Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D: Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008, 59:1690-1697.
8. Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D: Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2012, 71:1524-1529.
9. Jess T, Gamborg M, Munkholm P, Sorensen TI: Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol 2007, 102:609-617.
10. Dorn SD, Sandler RS: Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. Am J Gastroenterol 2007, 102:662-667.
11. Ha C, Magowan S, Accortt NA, Chen J, Stone CD: Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol 2009, 104:1445-1451.
12. Bernstein CN, Wajda A, Blanchard JF: The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol 2008, 6:41-45
13. Dart AM, Lacombe F, Yeoh JK, Cameron JD, Jennings GL, Laufer E, Esmore DS: Aortic distensibility in patients with isolated hypercholesterolaemia, coronary artery disease, or cardiac transplant. Lancet 1991, 338:270-273
14. Lakatta EG, Levy D: Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation 2003, 107:139-146
15. Dart AM, Kingwell BA: Pulse pressure-a review of mechanisms and clinical relevance. J Am Coll Cardiol 2001, 37:975-984
16. Munakata MNT, Tayama J, Yoshinaga K, Toyota T Brachial-Ankle pulse wave velocity as a novel measure of arterial stiffness: present evidences and perspectives. Curr Hypertens Rev 2005, 1:223-234.
17. Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, Yamamoto Y, Hori S: Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 2003,26:615-622
18. Mancini GB, Dahlof B, Diez J: Surrogate markers for cardiovascular disease: structural markers. Circulation 2004, 109:IV22-IV30
19. Heald CL, Fowkes FG, Murray GD, Price JF, Ankle Brachial Index C: Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis 2006, 189:61-69
20. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324
21. Montes M, Jaensson EA, Orozco AF, Lewis DE, Corry DB: A general method for bead-enhanced quantitation by flow cytometry. J Immunol Methods 2006, 317:45-55.
22. Osterman MT, Yang YX, Brensinger C, Forde KA, Lichtenstein GR, Lewis JD: No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease. Clin Gastroenterol Hepatol 2011, 9:875-880
23. Andersohn F, Waring M, Garbe E: Risk of ischemic stroke in patients with Crohn's disease: a population-based nested case-control study. Inflamm Bowel Dis 2011, 16:1387-1392.
24. Yarur AJ, Deshpande AR, Pechman DM, Tamariz L, Abreu MT, Sussman DA: Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol 2011, 106:741-747
25. Rungoe C, Basit S, Ranthe MF, Wohlfahrt J, Langholz E, Jess T Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study. Gut 2012, 62:689-694
26. Fumery M, Xiaocang C, Dauchet L, Gower-Rousseau C, Peyrin-Biroulet L, Colombel JF: Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies. J Crohns Colitis 2014, 8:469-479.
27. Goodson NJ, Symmons DP, Scott DG, Bunn D, Lunt M, Silman AJ: Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum 2005, 52:2293-2299.
28. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101:1767-1772.
29. Chung CP, Giles JT, Petri M, Szklo M, Post W, Blumenthal RS, Gelber AC, Ouyang P, Jenny NS, Bathon JM: Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis. Semin Arthritis Rheum 2012, 41:535-544.
30. Sappati Biyyani RS, Fahmy NM, Baum E, Nelson KM, King JF: Inflammatory bowel disease and coronary artery disease. Indian J Gastroenterol 2009, 28:28-30
31. Gandhi S, Narula N, Marshall JK, Farkouh M: Are patients with inflammatory bowel disease at increased risk of coronary artery disease? Am J Med 2012, 125:956-962.
32. Theocharidou E, Mavroudi M, Soufleris K, Griva T, Giouleme O, Athyros VG, Karagiannis A: Aortic stiffness in patients with inflammatory bowel diseases. Hellenic J Atherosclerosis 2013, 4:200-207.
33. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM: Inflammation, immunity, and hypertension. Hypertension 2011, 57:132-140.
34. Gregor MF, Hotamisligil GS: Inflammatory mechanisms in obesity. Annu Rev Immunol 2011, 29:415-445.
35. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-1830.
36. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M: IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005, 11:191-198.
37. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334.
38. Esteve E, Ricart W, Fernandez-Real JM: Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 2005, 24:16-31.
39. McGillicuddy FC, de la Llera MM, Hinkle CC, Joshi MR, Chiquoine EH, Billheimer JT, Rothblat GH, Reilly MP: Inflammation impairs reverse cholesterol transport in vivo. Circulation 2009, 119:1135-1145.
40. Maki-Petaja KM, Hall FC, Booth AD, Wallace SM, Yasmin, Bearcroft PW, Harish S, Furlong A, McEniery CM, Brown J, Wilkinson IB: Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation 2006, 114:1185-1192.
41. Protogerou AD, Zampeli E, Fragiadaki K, Stamatelopoulos K, Papamichael C, Sfikakis PP: A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis. Atherosclerosis 2011, 219:734-736.
42. Zanoli L, Cannavo M, Rastelli S, Di Pino L, Monte I, Di Gangi M, Boutouyrie P, Inserra G, Laurent S, Castellino P: Arterial stiffness is increased in patients with inflammatory bowel disease. J Hypertens 2012, 30:1775-1781.
43. Cypiene A, Laucevicius A, Venalis A, Ryliskyte L, Dadoniene J, Petrulioniene Z, Kovaite M, Laskova V, Gintautas J: Non-invasive assessment of arterial stiffness indices by applanation tonometry and pulse wave analysis in patients with rheumatoid arthritis treated with TNF-alpha blocker remicade (infliximab). Proc West Pharmacol Soc 2007, 50:119-122.
44. Yasmin MECM, Wallace S, Mackenzie IS, Cockcroft JR, Wilkinson IB: C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 2004, 24:969-974.
45. Mahmud A, Feely J: Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 2005, 46:1118-1122.
46. Okamura T, Moriyama Y, Kadowaki T, Kanda H, Ueshima H: Non-invasive measurement of brachial-ankle pulse wave velocity is associated with serum C-reactive protein but not with alpha-tocopherol in Japanese middle-aged male workers. Hypertens Res 2004, 27:173-180.
47. Diehm C, Lange S, Darius H, Pittrow D, von Stritzky B, Tepohl G, Haberl RL, Allenberg JR, Dasch B, Trampisch HJ: Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006, 27:1743-1749.
48. Criqui MH, Denenberg JO, Langer RD, Fronek A: The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 1997, 2:221-226.
49. Tanaka H, Munakata M, Kawano Y, Ohishi M, Shoji T, Sugawara J, Tomiyama H, Yamashina A, Yasuda H, Sawayama T, Ozawa T: Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens 2009, 27:2022-2027.
50. Tsuchikura S, Shoji T, Kimoto E, Shinohara K, Hatsuda S, Koyama H, Emoto M, Nishizawa Y: Brachial-ankle pulse wave velocity as an index of central arterial stiffness. J Atheroscler Thromb 2010, 17:658-665.
51. Sugawara J, Hayashi K, Yokoi T, Cortez-Cooper MY, DeVan AE, Anton MA, Tanaka H: Brachial-ankle pulse wave velocity: an index of central arterial stiffness? J Hum Hypertens 2005, 19:401-406.
52. Vlachopoulos C, Aznaouridis K, Terentes-Printzios D, Ioakeimidis N, Stefanadis C: Prediction of cardiovascular events and all-cause mortality with brachial-ankle elasticity index: a systematic review and meta-analysis. Hypertension 2012, 60:556-562.